Literature DB >> 19347865

Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.

Neal A L Cody1, Zhen Shen, Jean-Sebastien Ripeau, Diane M Provencher, Anne-Marie Mes-Masson, Mario Chevrette, Patricia N Tonin.   

Abstract

The genetic analysis of nontumorigenic radiation hybrids generated by transfer of chromosome 3 fragments into the tumorigenic OV-90 ovarian cancer cell line identified the 3p12.3-pcen region as a candidate tumor suppressor gene (TSG) locus. In the present study, polymorphic microsatellite repeat analysis of the hybrids further defined the 3p12.3-pcen interval to a 16.1 Mb common region containing 12 known or hypothetical genes: 3ptel-ROBO2-ROBO1-GBE1-CADM2-VGLL3-CHMP2B-POU1F1-HTR1F-CGGBP1-ZNF654-C3orf38-EPHA3-3pcen. Seven of these genes, ROBO1, GBE1, VGLL3, CHMP2B, CGGBP1, ZNF654, and C3orf38, exhibited gene expression in the hybrids, placing them as top TSG candidates for further analysis. The expression of all but one (VGLL3) of these genes was also detected in the parental OV-90 cell line. Mutations were not identified in a comparative sequence analysis of the predicted protein coding regions of these candidates in OV-90 and donor normal chromosome 3 contig. However, the nondeleterious sequence variants identified in the transcribed regions distinguished parent of origin alleles for ROBO1, VGLL3, CHMP2B, and CGGBP1 and cDNA sequencing of the hybrids revealed biallelic expression of these genes. Interestingly, underexpression of VGLL3 and ZNF654 were observed in malignant ovarian tumor samples as compared with primary cultures of normal ovarian surface epithelial cells or benign ovarian tumors, and this occurred regardless of allelic content of 3p12.3-pcen. The results taken together suggest that dysregulation of VGLL3 and/or ZNF654 expression may have affected pathways important in ovarian tumorigenesis which was offset by the transfer of chromosome 3 fragments in OV-90, a cell line hemizygous for 3p.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19347865     DOI: 10.1002/mc.20535

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  21 in total

Review 1.  From vestigial to vestigial-like: the Drosophila gene that has taken wing.

Authors:  Emilie Simon; Corinne Faucheux; Alain Zider; Nadine Thézé; Pierre Thiébaud
Journal:  Dev Genes Evol       Date:  2016-04-26       Impact factor: 0.900

2.  Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway.

Authors:  Naoto Hori; Kazuyuki Okada; Yuki Takakura; Hiroyuki Takano; Naoto Yamaguchi; Noritaka Yamaguchi
Journal:  J Biol Chem       Date:  2020-05-08       Impact factor: 5.157

3.  VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer.

Authors:  Karen Gambaro; Michael C J Quinn; Paulina M Wojnarowicz; Suzanna L Arcand; Manon de Ladurantaye; Véronique Barrès; Jean-Sébastien Ripeau; Ann M Killary; Elaine C Davis; Josée Lavoie; Diane M Provencher; Anne-Marie Mes-Masson; Mario Chevrette; Patricia N Tonin
Journal:  Mol Oncol       Date:  2013-01-16       Impact factor: 6.603

4.  3'UTR elements inhibit Ras-induced C/EBPβ post-translational activation and senescence in tumour cells.

Authors:  Sandip K Basu; Radek Malik; Christopher J Huggins; Sook Lee; Thomas Sebastian; Krisada Sakchaisri; Octavio A Quiñones; W Gregory Alvord; Peter F Johnson
Journal:  EMBO J       Date:  2011-07-29       Impact factor: 11.598

5.  Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer.

Authors:  Ernest K Amankwah; Linda E Kelemen; Qinggang Wang; Honglin Song; Georgia Chenevix-Trench; Jonathan Beesley; Penelope M Webb; Celeste L Pearce; Anna H Wu; Malcolm C Pike; Daniel O Stram; Jenny Chang-Claude; Shan Wang-Gohrke; Roberta B Ness; Ellen L Goode; Julie M Cunningham; Brooke L Fridley; Robert A Vierkant; Shelley S Tworoger; Alice S Whittemore; Valerie McGuire; Weiva Sieh; Simon A Gayther; Aleksandra Gentry-Maharaj; Usha Menon; Susan J Ramus; Mary Anne Rossing; Jennifer A Doherty; Marc T Goodman; Michael E Carney; Galina Lurie; Lynne R Wilkens; Susanne Krüger Kjær; Estrid Høgdall; Daniel W Cramer; Kathryn L Terry; Montserrat Garcia-Closas; Hannah Yang; Jolanta Lissowska; Hoda Anton-Culver; Argyrios Ziogas; Joellen M Schildkraut; Andrew Berchuck; Paul D P Pharoah
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-03-17       Impact factor: 4.254

6.  Vestigial-Like 3 Plays an Important Role in Osteoblast Differentiation by Regulating the Expression of Osteogenic Transcription Factors and BMP Signaling.

Authors:  Haoze Yuan; Mika Ikegame; Yoko Fukuhara; Fumiko Takemoto; Yaqiong Yu; Jumpei Teramachi; Yao Weng; Jiajie Guo; Daisuke Yamada; Takeshi Takarada; Ying Li; Hirohiko Okamura; Bin Zhang
Journal:  Calcif Tissue Int       Date:  2022-06-24       Impact factor: 4.000

7.  Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours.

Authors:  Ashley H Birch; Suzanna L Arcand; Kathleen K Oros; Kurosh Rahimi; A Kevin Watters; Diane Provencher; Celia M Greenwood; Anne-Marie Mes-Masson; Patricia N Tonin
Journal:  PLoS One       Date:  2011-12-06       Impact factor: 3.240

Review 8.  Emerging roles of TEAD transcription factors and its coactivators in cancers.

Authors:  Ajaybabu V Pobbati; Wanjin Hong
Journal:  Cancer Biol Ther       Date:  2013-02-04       Impact factor: 4.742

9.  NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.

Authors:  Vladimir Kashuba; Alexey A Dmitriev; George S Krasnov; Tatiana Pavlova; Ilya Ignatjev; Vasily V Gordiyuk; Anna V Gerashchenko; Eleonora A Braga; Surya P Yenamandra; Michael Lerman; Vera N Senchenko; Eugene Zabarovsky
Journal:  Int J Mol Sci       Date:  2012-10-18       Impact factor: 5.923

10.  Weighted Gene Coexpression Network Analysis to Construct Competitive Endogenous RNA Network in Chromogenic Renal Cell Carcinoma.

Authors:  Yong-Bo Chen; Liang Gao; Jin-Dong Zhang; Jiang Guo; Ping-Hong You; Liang-You Tang; Ying-Wen Liu
Journal:  Biomed Res Int       Date:  2021-06-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.